TRANSGENE S.A.

Patent Owner

Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5689
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 35218
 
 
 
C07K PEPTIDES 1297
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 785
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 789
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 580
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 586
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5160
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2112
 
 
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 189

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0141,039 Biomarker for Monitoring PatientsJan 08, 14May 22, 14[A61K]
2014/0086,958 Biomarker for Selecting Patients and Related MethodsSep 18, 13Mar 27, 14[G01N]
2014/0073,033 METHOD FOR ORTHOPOXVIRUS PRODUCTION AND PURIFICATIONNov 12, 13Mar 13, 14[C12N]
2014/0057,972 ANTIBODY AGAINST THE CSF-1RJul 01, 13Feb 27, 14[C07K]
2014/0023,686 SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSEMay 23, 13Jan 23, 14[G01N]
2013/0287,737 Poxviral Oncolytic VectorsFeb 27, 13Oct 31, 13[A61K]
2013/0289,250 ANTIBODY AGAINST THE CFR-1RMay 17, 13Oct 31, 13[C07K]
2013/0244,246 IMMORTALIZED AVIAN CELL LINES COMPRISING E1A NUCLEIC ACID SEQUENCESDec 21, 12Sep 19, 13[C12N]
2013/0236,929 IMMORTALIZED AVIAN CELL LINES AND USE THEREOFFeb 25, 13Sep 12, 13[C12N, C12P]
2013/0095,557 IMMORTALIZED AVIAN CELL LINESJun 29, 11Apr 18, 13[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,778,328 Poxviral oncolytic vectorsNov 17, 08Jul 15, 14[C12N, A61K]
8,778,675 Immortalized avian cell lines and use thereofFeb 25, 13Jul 15, 14[C12N]
8,609,392 Method for orthopoxvirus production and purificationMay 11, 10Dec 17, 13[C12N]
8,604,170 Antibody against the CSF-1RMar 11, 09Dec 10, 13[C12P, C07K]
8,541,004 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic useSep 23, 11Sep 24, 13[C12N, A61K]
8,513,018 Immortalized avian cell linesMay 29, 12Aug 20, 13[C12N, C12P]
8,470,591 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammalOct 26, 05Jun 25, 13[C12N, C07H, A01N]
8,470,977 Antibody against the CSF-1RFeb 14, 11Jun 25, 13[C12P, C07K]
8,445,270 Immortalized avian cell lines and use thereofMay 11, 10May 21, 13[C12N]
8,420,103 Papillomavirus vaccinesJan 29, 08Apr 16, 13[C12N, A61P, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0039,891 POXVIRAL ONCOLYTIC VECTORSSep 15, 12Feb 14, 13[C12N, A61P, A61K]
2012/0190,100 ENZYMATIC COMPOSITION FOR THE DIGESTION OF CHICKEN EMBRYOSJul 21, 10Jul 26, 12[C12N, C12S]
2011/0312,525 SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSEJan 18, 10Dec 22, 11[C40B, G01N]
2011/0287,089 USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACTION FOR IMMUNE STIMULATIONJan 08, 10Nov 24, 11[A61P, A61K]
2011/0117,578 BIOMARKER FOR SELECTING PATIENTS AND RELATED METHODSMay 27, 09May 19, 11[C12Q, G01N]
2010/0150,969 IMMUNE RESPONSEDec 04, 07Jun 17, 10[A61P, A61K]
2010/0129,403 RECOMBINANT VIRAL VACCINEJun 15, 07May 27, 10[A61P, A61K]
2010/0074,869 Multifunctional CytokinesSep 15, 09Mar 25, 10[C12N, A61P, C12P, A61K]
2010/0061,957 HPV-16-BASED PAPILLOMAVIRUS VACCINESApr 17, 07Mar 11, 10[A61P, A61K]
2010/0055,069 HPV-18-BASED PAPILLOMAVIRUS VACCINESApr 17, 07Mar 04, 10[C07H, A61P, A61K, C07K]
2009/0317,422 USE OF PPD FOR THE ADJUVANTATION OF A NUCLEIC ACID VACCINEJun 14, 07Dec 24, 09[A61P, A61K]
7,608,267 Multifunctional cytokinesJul 21, 04Oct 27, 09[C07H, C12P, A61K, C07K]
7,560,527 Modified adenovirus fibre and usesNov 23, 00Jul 14, 09[C12N, A61K, C07K]
7,534,585 Multifunctional cytokinesJul 20, 04May 19, 09[C12N]
7,482,155 Chimeric promoters for controlling expression in smooth muscle cellsJul 04, 01Jan 27, 09[C12N, C07H, A61K]
2008/0227,082 METHOD OF IDENTIFYING A MHC CLASS I RESTRICTED T CELL RESPONSEMar 04, 08Sep 18, 08[C12Q]
7,256,036 Modified adenoviral fiber and target adenovirusesApr 01, 03Aug 14, 07[C12N]
2007/0072,176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virusAug 11, 06Mar 29, 07[C07H, C12Q, A61K, C07K]
2006/0269,562 POLYPEPTIDES F' OF THE HEPATITIS C VIRUS, T EPITOPEO, AND THE DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOFDec 29, 03Nov 30, 06[C12N, C07H, C12Q, A61K, C07K]
2006/0140,920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domainOct 06, 05Jun 29, 06[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.